Introduction {#sec1}
============

Maturation of viral polyproteins is essential for the replication and production of viruses. In human immunodeficiency virus-1 (HIV-1), reverse transcriptase (RT) is expressed as a part of the viral Gag-Pol polyprotein, which is cleaved by HIV-1 protease (PR) to form a mature RT heterodimer composed of 66 (p66) and 51 kDa (p51) subunits (p66/p51).^[@ref1],[@ref2]^ The p51 subunit is generated upon removal of most of the ribonuclease H (RNH) domain from p66.^[@ref3]−[@ref5]^ The maturation of RT from the Gag-Pol polyprotein is complex and varies depending on the environment and experimental conditions.^[@ref6]−[@ref15]^

At a molecular level, studies on RT maturation and its dependence on the protein concentration and dimerization have shown that efficient RT maturation requires p66 homodimer formation, p66/p66, prior to PR processing at the p51-RNH site.^[@ref8],[@ref16],[@ref17]^ We recently showed that such maturation of RT is significantly enhanced in the presence of tRNA^Lys3^*in vitro* and at the cellular level.^[@ref18],[@ref19]^ Because the p51-RNH cleavage site in p66/p66 is buried within the RNH domain in the mature RT, the presence of such an enhancer explains how the RT precursor can cross the energy barrier for p66/p51 formation. tRNA^Lys3^ is known to be recruited to the virus in complex with lysyl--tRNA synthetase (LysRS), a 68 kDa protein,^[@ref20]−[@ref23]^ and we have shown that knockdown of LysRS results in the accumulation of p66, reducing the production of p66/p51 at the cellular level.^[@ref19]^ Because tRNA^Lys3^ serves as a primer to initiate reverse transcription and is known to interact with mature RT in complex with viral RNA,^[@ref2]^ we considered it important to further characterize whether LysRS might play a direct role in our model of tRNA^Lys3^-facilitated maturation of RT or not.

LysRS is a 68 kDa protein, exists primarily as a homodimer in solution, and is structured from residue 70 to 576.^[@ref24]^ LysRS interacts with tRNA^Lys3^ with a dissociation constant (*K*~D~) of 60--900 nM^[@ref25]−[@ref27]^ and with a Michaelis constant (*K*~m~) for aminoacylation of ∼100 μM.^[@ref25]^ Aminoacylation does not affect incorporation of tRNA^Lys3^ to the virus.^[@ref23]^ The *K*~D~ of tRNA^Lys3^ dissociation from LysRS is compatible with the apparent *K*~D~ of tRNA^Lys3^ dissociation from p66/p66, ∼70 nM, and with that of the p66 homodimer dissociation, ∼4 μM.^[@ref18],[@ref28],[@ref29]^ In the virus, LysRS has been proposed to interact with Gag and Gag-Pol.^[@ref30]−[@ref36]^ Specifically, LysRS has been suggested to interact with the connection and RNase H regions in the RT domain of the Gag-Pol polyprotein.^[@ref32]^ However, whether LysRS affects RT maturation is unknown.

Here, we present data from *in vitro* RT maturation assays, size exclusion chromatography (SEC), SEC-multiangle light scattering (SEC-MALS), and gel-mobility shift assays to investigate the effect of LysRS on *in vitro* RT maturation. Briefly, a LysRS--p66/p66 interaction was not detected, and RT maturation was not suppressed by LysRS *in vitro*. We conclude that a free tRNA^Lys3^ fraction in the LysRS--tRNA^Lys3^ equilibrium is sufficient to enhance RT maturation.

Results {#sec2}
=======

LysRS--tRNA^Lys3^ Interaction {#sec2.1}
-----------------------------

Prior to studying the LysRS effect on RT maturation, we first employed SEC-MALS to characterize the interaction between purified LysRS and tRNA^Lys3^. LysRS at two different injection concentrations, 10 and 40 μM ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}A,B), gave maximum molecular masses of 127.3 ± 2.4 and 128.4 ± 3.4 (kg/mol), respectively, both similar to the expected molecular mass of a LysRS homodimer, 136 kDa. Each mass value, as listed in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, is an average of those obtained within the selected region of the respective elution peak (*i.e*., symbols in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). This analysis provides qualitative estimates of the species observed in each elution profile.

![SEC-MALS of (A) 10 μM LysRS, (B) 40 μM LysRS, (C) 40 μM LysRS and 5 μM tRNA^Lys3^, and (D) 40 μM LysRS and 20 μM tRNA^Lys3^. The concentration is the injection concentration. Each graph indicates the UV 280 nm elution profile (solid line with the left vertical scale) and estimated molecular mass from MALS (symbols with the right vertical scale). In the protein and RNA mixed samples, the entire mass is shown by black symbols, and each mass component, either protein or RNA, is shown by gray symbols (see [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).](ao0c01449_0001){#fig1}

###### Deconvolution[a](#t1fn1){ref-type="table-fn"} of the LysRS--tRNA^Lys3^ SEC-MALS Data Obtained in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}D

  elution volume (mL)   entire mass (kg/mol)   protein mass (kg/mol)                    tRNA mass (kg/mol)                       estimated species
  --------------------- ---------------------- ---------------------------------------- ---------------------------------------- -------------------
  ∼11.2                 202.5                  140.5                                    62.1                                     LysRS dimer--
                        (±11.6)                (± 9.7)                                  (± 2.0)                                  2 tRNA
                                                                                                                                  
  ∼12.0                 146.9                  116.4                                    30.5                                     LysRS dimer--
                        (±1.0)                 (±3.4)                                   (±3.9)                                   1tRNA
                                                                                                                                  
  ∼12.8                 129.4                  123.8                                    [b](#t1fn2){ref-type="table-fn"}         LysRS dimer
                        (±2.7)                 (±2.6)[b](#t1fn2){ref-type="table-fn"}                                             
                                                                                                                                  
  ∼14.0                 27.9                   [c](#t1fn3){ref-type="table-fn"}         27.9                                     tRNA
                        (±1.1)                                                          (±1.1)[c](#t1fn3){ref-type="table-fn"}    

Data were analyzed assuming a protein--nucleic acid complex. Note, tRNA and LysRS homodimer molecular weights are 25 and 136 kDa, respectively.

Fit indicated that tRNA did not exist.

Fit indicated that protein did not exist. The entire mass was attributed only to tRNA.

Next, SEC-MALS experiments were performed by injecting 40 μM LysRS mixed with 5 μM tRNA^Lys3^ ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}C). The elution profile exhibited a fraction of a tRNA^Lys3^--LysRS complex at 1:1 tRNA^Lys3^--LysRS stoichiometry, with molecular masses at 26.9 ± 2.8 and 123.9 ± 1.5 (kg/mol), respectively, which is consistent with their known molecular weights, 25 and 136 kDa, respectively. When a mixture of 40 μM LysRS with 20 μM tRNA^Lys3^ was injected, two additional fractions were observed. One, the earliest elution peak, was from the tRNA^Lys3^--LysRS complex at 2:1 tRNA^Lys3^--LysRS stoichiometry, and the other, the last elution peak, was a free tRNA^Lys3^ fraction ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}D and [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). We verified these observations by recording additional SEC experiments in which the elution was detected using UV at 254 and 280 nm wavelengths ([Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01449/suppl_file/ao0c01449_si_001.pdf)). Based on the known *K*~D~ of the tRNA^Lys3^--LysRS complex, 0.93 ± 0.32 μM,^[@ref27]^ observation of a free tRNA^Lys3^ fraction is reasonable at ∼μM protein and RNA concentrations (assuming 10-fold dilution in the column). Note, because LysRS has only two Trp residues, its extinction coefficient at UV 280 nm is 43,780 M^--1^ cm^--1^ and is approximately 10 times smaller than that of the tRNA^Lys3^, ∼350,000 M^--1^ cm^--1^. Thus, although the intensity of the free tRNA^Lys3^ in the UV elution profile, as shown in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}D, is much higher than those of LysRS--tRNA^Lys3^ complexes, the actual population of the free tRNA^Lys3^ is approximately equivalent to the bound form.

Effect of LysRS on *In Vitro* RT Maturation {#sec2.2}
-------------------------------------------

We next performed a set of *in vitro* RT maturation assays with or without LysRS. Production of p51 subunit from p66 was monitored by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) following incubation of purified p66 with HIV-1 PR for varying amounts of time.^[@ref18]^ Generation of equivalent amounts of p66 and p51 is indicative of p66/p51 heterodimer production. As shown previously,^[@ref18]^ incubation of p66 alone with PR did not generate significant p66/p51 heterodimer ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}A) while incubation in the presence of tRNA^Lys3^ did ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}B). A similar result was obtained in the presence of LysRS ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}C,D): p51 band generation was more significant in the presence of tRNA^Lys3^ than in its absence. The enhancement of p66/p51 production in the presence of tRNA^Lys3^ is not due to the PR--tRNA^Lys3^ interaction, as we demonstrated previously.^[@ref18]^ Whether LysRS was present or not, 30--40% of p66 was cleaved to p66/p51 at the 20 min time-point in the presence of tRNA^Lys3^ ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}E). Quantification of p66/p51 band intensity at the 20 min time-point suggested slightly higher p66/p51 production in the presence of LysRS, compared to the absence of LysRS. However, the reaction rates (measurements taken at initial time points) were not substantially different between these two conditions ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}E). Thus, we conclude that LysRS does not have an impact on p66/p51 production neither alone nor in the presence of tRNA^Lys3^.

![RT maturation assay: time-dependent proteolytic cleavage of p66 by HIV-1 PR monitored by SDS-PAGE. Cleavage experiments were conducted in the (A,B) absence or (C,D) presence of LysRS, and/or (B,D) presence or (A,C) absence of tRNA^Lys3^. Panel (E) indicates p66/p51 production, calculated based on the p51 band intensities of three repeated data sets (additional data in [Figure S2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01449/suppl_file/ao0c01449_si_001.pdf)). The concentrations of LysRS, p66, tRNA^Lys3^, and PR were 4, 8, 4, and 1 μM, respectively.](ao0c01449_0002){#fig2}

LysRS Does Not Interact with RT {#sec2.3}
-------------------------------

To understand the underlying mechanism of the above-mentioned RT maturation results, we conducted molecular-interaction studies. We performed SEC experiments with LysRS alone ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}A), p66 alone ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}B), and LysRS mixed with p66 ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}C). The elution profile of the mixed sample was explained well by superimposing it with those of the two isolated proteins ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}C), demonstrating that LysRS and p66 do not interact in a substantial way when present at μM protein concentrations. We next performed SEC-MALS experiments of LysRS and p66 in the presence of tRNA^Lys3^. We used SEC-MALS, instead of SEC, to enable identification of each elution peak component as much as possible. A mixture containing 5 μM tRNA^Lys3^, 40 μM LysRS, and 40 μM p66 generated the following SEC-MALS elution peaks: (i) free p66, (ii) superimposed peaks of p66--tRNA^Lys3^ complex and of p66/p66, (iii) superimposed peaks presumably of p66/p66--tRNA^Lys3^ and of LysRS (could not be deconvoluted because of three different species), and (iv) the LysRS--tRNA^Lys3^ complex ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}D). The same experiment with a higher tRNA^Lys3^ concentration generated a molecular mass that corresponded to a LysRS homodimer bound to two tRNA^Lys3^ ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}E). The fraction at ∼11 mL showed a gradient of molecular masses, including a high molecular mass component, perhaps tetramer of LysRS. Importantly, an explicit elution peak indicating the presence of the p66/p66--tRNA^Lys3^--LysRS complex was not observed ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}E). Thus, we conclude that both in the presence and absence of tRNA^Lys3^, direct interaction of LysRS dimer and p66 (or p66/p66) is not detectable at the μM concentration range.

![(A--C) SEC and (D,E) SEC-MALS elution profiles showing no interaction between LysRS and p66 in the (A--C) absence and (D,E) presence of tRNA^Lys3^: (A) 30 μM LysRS, (B) 30 μM p66, (C) 30 μM LysRS and 30 μM p66, (D) 40 μM LysRS, 40 μM p66, and 5 μM tRNA^Lys3^, and (E) 40 μM LysRS, 40 μM p66, and 20 μM tRNA^Lys3^. In (C), dotted and dashed lines are taken from (A,B). In (D,E), the entire mass is shown by black symbols, individual mass component, either protein or RNA, is shown by gray symbols, and those that could not be deconvoluted are shown with "X." In (D), mixed species are annotated with gray characters (see the details, as listed in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}).](ao0c01449_0003){#fig3}

To verify the above observation, we studied tRNA^Lys3^ interactions with each individual protein and then examined competition between LysRS and p66 for tRNA^Lys3^ binding using a gel-based shift mobility assay ([Figures [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"} and [S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01449/suppl_file/ao0c01449_si_001.pdf)). In the experiment for binary complex formation with tRNA^Lys3^ and LysRS or p66, the tRNA^Lys3^ band clearly shifted with increasing concentrations of proteins ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}A,B). Consistent with a previous observation,^[@ref26]^ LysRS was observed to bind one or two tRNA^Lys3^ molecules: at lower LysRS concentrations (1--2 μM), two tRNA^Lys3^ molecules bound the LysRS dimer, whereas at higher LysRS concentrations (4--8 μM), LysRS dimer bound one tRNA^Lys3^ ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}A). Note, because LysRS dimer bound to two tRNA is more negatively charged than LysRS bound to one tRNA, it migrates faster in a native gel.^[@ref26]^ In the tRNA^Lys3^--p66 interaction study, the well-defined free tRNA^Lys3^ band was present at low p66 concentrations and shifted to a diffuse band in the presence of higher p66 concentrations (\>2 μM p66), reflecting generation of p66--tRNA^Lys3^ and p66/p66--tRNA^Lys3^ complexes ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}B), which is in agreement with our previous observation.^[@ref18]^

![Competitive gel-shift assay to characterize molecular interactions of (A,B) 0.5 μM tRNA^Lys3^ with (A) LysRS or (B) p66 at different protein concentrations, (C) 0.5 μM tRNA^Lys3^ and 8 μM LysRS with escalating p66 concentrations, or (D) 0.5 μM tRNA^Lys3^ and 8 μM p66 with LysRS at escalating protein concentrations. Binding experiments were performed in 25 mM Bis--Tris buffer, containing 100 mM NaCl, at pH 7.0. Reactions were monitored by native polyacrylamide gel, and the gel was stained with SYBR gold to detect tRNA^Lys3^. The repeated gel ([Figure S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01449/suppl_file/ao0c01449_si_001.pdf)), run with similar conditions, reproduced the data.](ao0c01449_0004){#fig4}

In competition experiments, when p66 was added to a preincubated solution of LysRS and tRNA^Lys3^, a fraction of the LysRS--tRNA^Lys3^ complex decreased while fractions of p66--tRNA^Lys3^ and p66/p66--tRNA^Lys3^ increased ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}C and [S3C](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01449/suppl_file/ao0c01449_si_001.pdf)). When LysRS was added to the preincubated solution of p66 and tRNA^Lys3^, a LysRS--tRNA^Lys3^ complex band was observed ([Figures [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}D and [S3D](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01449/suppl_file/ao0c01449_si_001.pdf)). These data indicate that binding of tRNA^Lys3^ to p66 or p66/p66 is with an apparent affinity similar to that of tRNA^Lys3^ binding to LysRS, and neither is extremely high.

Effect of PR Processing of LysRS {#sec2.4}
--------------------------------

Interestingly, PR cleaved LysRS as well as p66 ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}D). This raised the possibility that LysRS cleavage releases tRNA^Lys3^ from the LysRS--tRNA^Lys3^ complex, preventing our observation of any effect of LysRS--tRNA^Lys3^ on RT maturation. To test this hypothesis, we first investigated whether cleavage of LysRS releases tRNA^Lys3^ from the LysRS--tRNA^Lys3^ complex by monitoring (i) the mobility of tRNA^Lys3^ in native gels of LysRS--tRNA^Lys3^ in the presence of PR ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}A) and (ii) the formation of LysRS cleavage products in denatured SDS-PAGE of LysRS in the presence of PR ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}B). The samples for both assays were obtained from the same time course experiments. Our results demonstrate that tRNA^Lys3^ remains bound to LysRS even after PR cleaves the protein ([Figures [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}A, [5](#fig5){ref-type="fig"}B, and [S4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01449/suppl_file/ao0c01449_si_001.pdf)).

![Processing of LysRS by HIV-1 PR in the presence of tRNA^Lys3^, (A) monitored by native-PAGE, (B) monitored by SDS-PAGE, and (C) in the absence or presence of tRNA^Lys3^, monitored by SDS-PAGE. Panels (A,B) were obtained from a single set of experiments, performed using 1 μM PR, 8 μM LysRS, and 2 μM tRNA^Lys3^. Panel (C) in the presence of tRNA^Lys3^ corresponds to a repeat of (A) but using 4 μM tRNA^Lys3^ and the control for the data in the absence of tRNA^Lys3^. Repeated data for (A,B) are also shown in [Figure S4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01449/suppl_file/ao0c01449_si_001.pdf). The full images and the repeated data for (C) are shown in [Figure S7](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01449/suppl_file/ao0c01449_si_001.pdf).](ao0c01449_0005){#fig5}

To identify the cleavage site, we performed mass spectrometry experiments. The data indicate that two fragments of LysRS were generated: (i) a fragment created by cleavage at an N-terminal D12-G13 site and (ii) a fragment generated by cleavage at a C-terminal A536-L537 site ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"} and [Figure S5](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01449/suppl_file/ao0c01449_si_001.pdf)). The cleavage at D12-G13 was most likely chemically induced by formic acid, which is known to be generated during the sample preparation for the mass spectrometry experiments, and D12-G13 is not a PR-recognized site.^[@ref37]−[@ref39]^ Indeed, this peptide cleavage was observed in the samples of LysRS alone as well as those treated with PR ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"} and [Figure S5](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01449/suppl_file/ao0c01449_si_001.pdf)). On the other hand, the C-terminal A536-L537 site is a peptide sequence that aspartic proteases are predicted to cleave.^[@ref38],[@ref39]^ Thus, we conclude that PR cleaves LysRS at A536-L537 to generate a 61.5 kDa product from the 68.2 kDa full-length LysRS. The A536-L537 site is not located at a random coil region but is in a short α-helix, near the loop region ([Figures S5A and S6](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01449/suppl_file/ao0c01449_si_001.pdf), discussed later). Importantly, the PR-cleaved C-terminal β-strand is located within a seven-stranded β-sheet that is sandwiched between α-helices. This may be one of the reasons why LysRS remained bound to tRNA^Lys3^ ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}A) even after PR cleavage at the C-terminal β-strand ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}B).

###### Deconvolution[a](#t2fn1){ref-type="table-fn"} of the LysRS--tRNA^Lys3^ SEC-MALS Data Obtained in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}E

  elution volume (mL)   entire mass (kg/mol)                       protein mass (kg/mol)              tRNA mass (kg/mol)                 estimated species
  --------------------- ------------------------------------------ ---------------------------------- ---------------------------------- -------------------------------------------------
  ∼11.2                 270.5                                      197.6                              62.1                               LysRS dimer--2 tRNA and a higher molecular mass
                        (±14.6)                                    (±12.3)                            (±2.0)                             
                                                                                                                                          
  ∼12.0                 160.7                                      128.8                              30.5                               LysRSdimer--1 tRNA and p66/p66--tRNA
                        (±2.0)                                     (±1.1)                             (±3.9)                             
                                                                                                                                          
  ∼12.8                 137--152[b](#t2fn2){ref-type="table-fn"}   [b](#t2fn2){ref-type="table-fn"}   [b](#t2fn2){ref-type="table-fn"}   X (LysRS dimer and p66/p66--tRNA)
                                                                                                                                          
  ∼13.6                 89.3                                       66.0                               23.3                               p66--tRNA
                        (±14.9)                                    (±7.2)                             (±2.4)                              
                                                                                                                                          
  ∼14.6                 69.5                                       59.6                               [c](#t2fn3){ref-type="table-fn"}   p66
                        (±1.2)                                     (±0.5)                                                                 

Data were analyzed assuming a protein--nucleic acid complex. Note that tRNA, LysRS homodimer, p66 molecular weights are 25, 136, and 66 kDa, respectively.

Fit was not obtained presumably due to the mixture of LysRS and p66/p66--tRNA species.

Fit indicated that tRNA did not exist.

###### Mass Spectrometry Data of LysRS in the Absence or Presence of PR, Examined with/without DTT[a](#t3fn1){ref-type="table-fn"}

  protein condition   experimental mass (Da)                     theoretical mass   estimated amino acid sequence
  ------------------- ------------------------------------------ ------------------ ---------------------------------------------------
  LysRS               68,162.3                                   68,162.17          LysRS full-length[b](#t3fn2){ref-type="table-fn"}
                      66,892.3                                   66,891.70          LysRS from G13 to the C-terminal end
  LysRS + DTT         68,162.4                                   68,162.17          LysRS full-length[b](#t3fn2){ref-type="table-fn"}
                      66,892.0                                   66,891.70          LysRS from G13 to the C-terminal end
  LysRS + PR          68,161.4                                   68,162.17          LysRS full-length[b](#t3fn2){ref-type="table-fn"}
                      66,891.4[c](#t3fn3){ref-type="table-fn"}   66,891.70          LysRS from G13 to the C-terminal end
                      61,521.5                                   61,521.61          LysRS from the N-terminal end to A536
  LysRS + DTT + PR    68,161.9                                   68,162.17          LysRS full-length[b](#t3fn2){ref-type="table-fn"}
                      66,891.6[c](#t3fn3){ref-type="table-fn"}   66,891.70          LysRS from G13 to the C-terminal end
                      61,521.3                                   61,521.61          LysRS from the N-terminal end to A536

The convoluted mass profiles are shown in [Figure S5](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01449/suppl_file/ao0c01449_si_001.pdf).

This is the molecular mass with the N-terminal Gly and the C-terminal Gly.

This is due to chemical cleavage by formic acid^[@ref37]^ and is seen in the samples without PR too.

Because tRNA^Lys3^ binding to LysRS could potentially delay fragmentation of LysRS by PR, as observed from the intensity plot ([Figure S7C](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01449/suppl_file/ao0c01449_si_001.pdf)), we next compared the time course of LysRS cleavage by PR in the absence or presence of tRNA^Lys3^. Interestingly, cleavage of LysRS by PR was similar both in the absence and presence of tRNA^Lys3^ ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}C). Thus, the surrounding β-sheet and α-helices support the cleaved β-strand to fold the protein, and tRNA^Lys3^ binding is not a major factor in maintaining the fold of the cleaved LysRS. Note, the fraction of full-length and truncated forms of LysRS decreased with time in the presence of PR, indicating that PR can digest other sites in LysRS but at a rate slower than the A536-L537 site. Overall, a drastic dissociation of tRNA^Lys3^ from the LysRS--tRNA^Lys3^ complex did not occur upon PR cleavage of LysRS.

Discussion {#sec3}
==========

We previously found that the interaction of tRNA^Lys3^ with p66/p66 enhances specific cleavage by PR.^[@ref18],[@ref19]^ However, tRNA^Lys3^ is not recruited to the virus by itself and is known to be packaged in a complex with LysRS.^[@ref20],[@ref21],[@ref40],[@ref41]^ Thus, we tested whether LysRS affects RT maturation *in vitro*. Our observation of the LysRS interaction with tRNA^Lys3^ by SEC-MALS ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}) and the gel shift ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}A) are consistent with the previously published data.^[@ref26]^ Interestingly, we did not observe significant delay of RT maturation in the presence of LysRS ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). Consistent with this, we also did not observe p66/p66--LysRS interactions ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}), indicating that a ternary complex of LysRS--tRNA^Lys3^--p66/p66 is not formed in the conditions and concentration ranges that we examined. Similarly, we did not observe any effect of LysRS cleavage on tRNA^Lys3^ release ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}), indicating that LysRS digestion by PR is not a major mechanism to release tRNA^Lys3^ from LysRS. Instead, the apparent affinities of tRNA^Lys3^ to p66 and LysRS were similar to each other ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). Taken together, because of a similar moderate, ∼μM, apparent dissociation constants of LysRS--tRNA^Lys3^ and p66/p66--tRNA^Lys3^, a fraction of the free tRNA^Lys3^ may bind p66/p66 and enhance RT maturation ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}). Here, "apparent" includes the effect of the monomer--dimer equilibrium of p66. Such a conclusion is consistent with a model in which tRNA^Lys3^ transiently interacts with p66/p66 to promote maturation, rather than only stabilizing the produced p66/p51 form.

![Cartoon indicating the equilibrium between p66 (blue spheres) and tRNA^Lys3^ (red triangles), and between LysRS (pink oval) and tRNA^Lys3^. Based on our observation, we propose that a fraction of free tRNA^Lys3^ in the equilibrium of LysRS--tRNA^Lys3^ might be sufficient for RT maturation.](ao0c01449_0006){#fig6}

Our observations also provide information on the biophysical characteristics of human LysRS. LysRS is known to form a dimer in solution. Although elution peaks of both dimer and tetramer fractions have been shown in the previous gel-filtration chromatography studies (at a 1.7 μM loading concentration),^[@ref24]^ we did not see a significant tetramer fraction at a 30 μM loading concentration. Instead, the molecular masses estimated from MALS, 127.3 ± 2.4 and 128.4 ± 3.4 (kg/mol) for 10 and 40 μM injections, respectively, were ∼5% smaller than the expected molecular mass of a LysRS homodimer, 136 kDa ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). These molecular masses may indicate that the protein is in a monomer--dimer equilibrium, rather than a dimer--tetramer equilibrium. Our observation is consistent with the fact that light scattering indicates a hydrodynamic diameter for LysRS of ∼9.5 nm, which is smaller than the diameter estimated from a crystal structure of the dimer, 10.2 nm.^[@ref35]^

The C-terminal A536-L537 cleavage site in LysRS is not located in a random coil region but in a short α-helix (residues 530--539) near the loop region ([Figure S6A](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01449/suppl_file/ao0c01449_si_001.pdf)). This site is buried by the N-terminal domain (residues 1--215) of the other subunit in the homodimer crystal structure ([Figure S6B](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01449/suppl_file/ao0c01449_si_001.pdf)).^[@ref24]^ Because PR is not expected to be able to access such a buried site, our observation suggests that the N-terminal domain undergoes domain motion. This is consistent with the previous hydrogen--deuterium exchange and small-angle X-ray scattering study, showing flexibility of the N-terminal domain.^[@ref26]^ Importantly, the short α-helix (residues 530--539) directly interacts with the side chain of S207, the phosphorylation of which is critical for the release of LysRS from the multi-tRNA synthetase complex and the conformational change for it.^[@ref26],[@ref42]^ We also suggest that the helix itself may be more mobile, or shorter, to allow PR interaction with the A536-L537 site in solution.

With regard to the significance and consistency of our findings relative to previously described HIV-1 replication studies, we consider the following. Kleiman's group previously showed truncation of LysRS in the virus from ∼70 to ∼62 kDa.^[@ref20]^ This cleavage is likely the same C-terminal truncation that we observed from 68.2 to 61.5 kDa (determined by mass spectrometry). Importantly, our data indicate that LysRS can carry tRNA^Lys3^ even after the cleavage. Thus, the truncation does not interfere with LysRS recruitment of tRNA^Lys3^ to the virus.^[@ref21]−[@ref23]^ Our observation is also consistent with what Kleiman found regarding the LysRS truncation in their virus experiments.^[@ref20]^ Based on our data, because the binding affinities of tRNA^Lys3^ with LysRS and p66 are moderate and these proteins do not directly interact with each other, p66/p66 could be matured with assistance from free tRNA^Lys3^ in a trimolecule equilibrium ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}).

While only two tRNA^Lys3^ molecules are known to be annealed to the viral RNA,^[@ref43]^ 20--25 tRNA^Lys3^ molecules, including the tRNA^Lys3^ isoacceptors, are in the virus.^[@ref21],[@ref44],[@ref45]^ Such a difference in the total number of tRNA^Lys3^ molecules present in the virus and the need for many tRNA^Lys3^ molecules may be explained if one considers the population of the free tRNA^Lys3^ molecules in the LysRS--tRNA^Lys3^ equilibrium: LysRS in the virus may store tRNA^Lys3^ and release it for use during RT maturation and formation of the reverse transcription initiation complex. However, other molecules are also known to interact with tRNA^Lys3^ in the virus.^[@ref46],[@ref47]^ Further studies are needed to address the molecular interactions that occur in the virus.

Our study clarified the relative interactions of tRNA^Lys3^ with LysRS and p66/p66 and the effects of PR cleavage on these proteins. Interestingly, we found that LysRS does not directly interact with p66/66 and does not greatly influence the tRNA^Lys3^ effect on RT maturation. PR cleavage of LysRS does not release tRNA^Lys3^ either. Given that the apparent dissociation constants of LysRS--tRNA^Lys3^ and p66/p66--tRNA^Lys3^ are moderate, ∼μM, and similar to each other, we propose that free tRNA^Lys3^ is present in an amount sufficient to enhance RT maturation, further supporting our proposed RT maturation model.^[@ref18],[@ref19]^ Our results are also significant in that they support previous structural studies,^[@ref25]−[@ref27]^ as discussed above.

Materials and Methods {#sec4}
=====================

Protein and tRNA Expression and Purification {#sec4.1}
--------------------------------------------

We purchased the human KARS-1 clone, UniProtKB---Q15046 (SYK_HUMAN), in pD441-NHT vector (ATUM, Newark, CA) and expressed the protein in *Escherichia coli* BL21 (DE3). KARS is the gene name of LysRS; we use LysRS to refer to the protein in order to be consistent with publications from the Musier-Forsyth and Kleiman groups.^[@ref20]−[@ref23]^ Protein was purified by a HisTrap HP column (GE Healthcare, USA) using the published protocol,^[@ref48]^ followed by overnight cleavage with TEV protease. Processed LysRS protein was collected in the flow-through after a second pass through a HisTrap HP column and finally purified using the HiTrap Q HP column (GE Healthcare) in 25 mM HEPES buffer, pH 7.5, containing 10% glycerol and 0.02% azide, with 1 M NaCl in elution buffer. Purified protein was buffer exchanged to 25 mM Bis--Tris buffer at pH 7.0, containing 250 mM NaCl and 50% glycerol, and stored at −80 °C. Throughout the process of protein purification, we added fresh 5 mM β-mercaptoethanol to the buffers immediately before their use. The protein concentration was determined by measuring absorbance at 280 nm with an extinction coefficient of 43,780 M^--1^ cm^--1^. Both gene sequencing and mass spectrometry consistently confirmed that the protein contained an N-terminal Gly at the TEV protease cleavage site and one Gly at the C-terminus.

HIV-1 p66 protein was prepared, as described previously.^[@ref18]^ tRNA^Lys3^ was prepared by *in vitro* transcription of its DNA using NTPs and T7 RNA polymerase, as described previously.^[@ref19]^ Note, tRNA^Lys3^ does not have amino-acyl modification. HIV-1 protease was expressed and purified from the inclusion body using gel-filtration in denaturing conditions and reverse-phase chromatography.^[@ref49],[@ref50]^

SEC-MALS Experiments {#sec4.2}
--------------------

SEC-MALS experiments were performed for the following samples: 10 μM LysRS; 40 μM LysRS; 40 μM LysRS with 5 μM tRNA^Lys3^; 40 μM LysRS with 20 μM tRNA^Lys3^; 40 μM LysRS and 40 μM p66 with 5 μM tRNA^Lys3^; 40 μM LysRS and 40 μM p66 with 20 μM tRNA^Lys3^. All SEC-MALS experiments were performed by injecting a 100 μL sample, pre-equilibrated and eluted with 25 mM Bis--Tris, pH 7.0, 100 mM NaCl, 0.02% sodium azide buffer at a flow rate of 0.5 mL/min at room temperature using an analytical Superdex 200 Increase 10/300 column (GE Healthcare) with in-line MALS, refractive index (Wyatt Technology, Inc., Santa Barbara, CA), and UV/vis (Waters Corporation, USA) detectors.

The molecular masses of the eluted protein species were determined using the ASTRA V.7.1.2 program (Wyatt Technologies). After the SEC-MALS elution profiles were obtained, we selected each elution region for the mass ASTRA calculation and determined the average and standard deviation of the mass for each selected region. For protein--RNA complex analysis, we implemented the protein conjugate analysis method within the ASTRA program (Wyatt Technologies). Briefly, the analysis requires that the individual constituents within a complex have unique UV extinction coefficients and/or refractive index increments. After selecting peaks of interest, we used the specific refractive index increment for protein, 0.185 mL/g, and that for polynucleotides, 0.17 mL/g; as well as the specific UV extinction coefficients for tRNA^Lys3^ and LysRS or p66, respectively.

SEC Experiments {#sec4.3}
---------------

SEC experiments were performed for 30 μM LysRS, 30 μM p66/p66, and their mixture using a 24 mL analytical Superdex 200 Increase 10/300 GL column (GE Healthcare), equilibrated with 25 mM Bis--Tris buffer, pH 7.0, containing 100 mM NaCl with 0.02% sodium azide, at a flow rate of 0.5 mL/min. In each experiment, a 50 μL of the sample was injected, and protein elution was monitored by UV absorbance at 254 and 280 nm.

Gel-Shift Mobility Assays {#sec4.4}
-------------------------

Gel-shift assays to characterize the tRNA^Lys3^ interaction with LysRS and p66 were performed by preincubating each protein at different concentrations, with 0.5 μM tRNA^Lys3^ in 25 mM Bis--Tris, pH 7.0, 100 mM NaCl buffer at room temperature. In a subset of experiments, 8 μM p66 or 8 μM LysRS was also included during the preincubation period of tRNA^Lys3^ with LysRS or p66, respectively. The samples were resolved by native-PAGE using precast 4--15% Tris-glycine gels (Bio-Rad) with 0.5× TBE buffer. Glycerol was added to the reaction mixtures prior to loading to obtain a final 10% glycerol concentration. Gels were stained with SYBR Safe DNA Gel Stain (Invitrogen, USA) and analyzed with an Amersham Imager 600 (GE Healthcare Life Sciences).

*In Vitro* RT Maturation Experiments {#sec4.5}
------------------------------------

The time course of proteolytic processing of 8 μM p66 by 1 μM PR, in the absence or presence of 4 μM of tRNA^Lys3^, was carried out in 20 mM sodium acetate, pH 5.2, at 37 °C. In parallel, the same experiments were conducted in the presence of 4 μM LysRS. Aliquots at different time points were collected, quenched by the addition of tricine sample loading buffer (Bio-Rad Laboratories, Berkeley, CA) and monitored by SDS-PAGE stained with Bio-Safe Coomassie (Bio-Rad), as described previously.^[@ref18]^ For quantification, these gel-based experiments were repeated at least three times.

Proteolysis of LysRS by PR {#sec4.6}
--------------------------

Two types of gel-based LysRS proteolysis experiments were performed. First, 8 μM LysRS in the presence of 2 μM tRNA^Lys3^ in 25 mM Bis--Tris, pH 7.0, 100 mM NaCl buffer was incubated at 37 °C with 1 μM HIV PR for different periods of time. The samples were then aliquoted and either (i) quenched with 100 μM protease inhibitor, darunavir, for detection of the LysRS--tRNA^Lys3^ interaction in native gels, or (ii) quenched by the addition of tricine sample loading buffer and denatured at 95 °C to detect LysRS cleavage by HIV-1 PR in SDS-gels. Second, to investigate the effect of tRNA^Lys3^ on PR-directed LysRS proteolysis, time course experiments were performed using 8 μM LysRS and 1 μM PR in the absence or presence of 4 μM tRNA^Lys3^. Cleavage was monitored using SDS-PAGE, as described earlier.

The proteolysis site within LysRS was assessed by mass-spectrometry. LysRS solution, at 10 μM, was incubated for 30 min in 25 mM Bis--Tris, pH 7.0, 100 mM NaCl buffer, either with or without dithiothreitol (DTT), or with or without 1 μM PR. In each, 2 μL of the sample solution was diluted to an 18 μL solution, containing 5% acetonitrile, 0.01% trifluoroacetic acid, and 0.1% formic acid, at pH 2.65 and injected into a Bruker Compact QTOF LC--MS/MS system (Bruker Daltonics Inc., Billerica, MA).

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acsomega.0c01449](https://pubs.acs.org/doi/10.1021/acsomega.0c01449?goto=supporting-info).Additional SEC elution profiles to demonstrate data reproducibility; SDS gel mages of the repeated RT maturation experiments; repeat of the competitive gel-shift assay to characterize molecular interactions; repeat of LysRS processing by active PR; mass spectrometry data of LysRS samples; ribbon presentation of LysRS; full image of LysRS cleavage by PR in the absence or presence of tRNALys3; and quantification of total gel intensity of full-length and cleaved product ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01449/suppl_file/ao0c01449_si_001.pdf))
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